Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-023581

Chief Executive Officer sold 13,000 shares at an average $77.72 ($1,010,357)

  • Chief Executive Officer acquired 13,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schenkein David P · Chief Executive Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2018-04-02 Exercise or conversion : show line 1 in the form +13,000 $0.30 $3,933 13,000 D
2018-04-02 Sale : show line 2 in the form −1,557 $75.54 $117,616 11,443 D
2018-04-02 Sale : show line 3 in the form −2,600 $76.40 $198,640 8,843 D
2018-04-02 Sale : show line 4 in the form −3,340 $77.76 $259,718 5,503 D
2018-04-02 Sale : show line 5 in the form −3,390 $78.59 $266,420 2,113 D
2018-04-02 Sale : show line 6 in the form −2,113 $79.49 $167,962 0 D
Open-market sales · 13,000 sh · avg $77.72 · $1,010,357

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-04-02 Exercise or conversion : show line 7 in the form Stock option (right to buy) −13,000 78,567 D
Loading xslF345X03/doc4.xml…